Table 1.

Overview of the DAPROCAdata

General information
Patient population	Incident prostate cancer	Data collection since February 2010
Data coverage	Nationwide	22 urological and oncological departments participating in data registration
Data collection	Continuous	Data linkage from central registries combined with online prospective data collection of key clinical variables by treating clinicians
Clinical quality indicators	N=10
Clinical data registration forms	Diagnosis Clinical Data Registration Form Urology Clinical Data Registration Form Oncology Clinical Data Registration Form
PROM questionnaires	Data collection since May 2011 At diagnosis 1-year follow-up 3-year follow-up
Treatment variables	Oncology Surgery Radiation therapy Endocrine treatment
Pathology variables	Gleason score TNM stage
Laboratory variable	PSA at diagnosis
Comorbidity variablesa	CCI 0= none 1= low 2= medium 3= high
Administrative variables	Region Hospital site Department

Note:

^aCCI scores are systematically added to DAPROCAdata during conversion to the DNKK.

Abbreviations: CCI, Charlson Comorbidity Index; DAPROCAdata, Danish Prostate Cancer Database; DNKK, Danish National Cancer Clinical Database; PROM, patient-reported outcome measures; PSA, prostate-specific antigen; TNM, tumor, node, and metastasis cancer stage classification.